The DOI matches its Crossref record.
Plasma fibronectin promotes thrombus growth and stability in injured arterioles
Open accessAbstract
Mice lacking both of the best-known platelet ligands, von Willebrand factor and fibrinogen, can still form occlusive thrombi in injured arterioles. The platelets of these animals accumulate excessive amounts of fibronectin (FN). These observations led us to examine the contribution of plasma FN (pFN) to thrombus formation. Inactivation of the FN gene in FN conditional knockout mice reduced pFN levels to <2% and platelet FN to ≈20% of the levels in similarly treated control mice. The mice were then observed in a model of arterial injury to evaluate their capacity to form thrombi. The deficiency of pFN did not affect the initial platelet adhesion, but a delay of several minutes in thrombus formation was observed in the arterioles of pFN-deficient mice as compared with control mice. The thrombi that formed in the absence of pFN were stably anchored to the vessel wall but continuously shed platelets or small platelet clumps, thus slowing their growth significantly; the platelet/platelet cohesion was apparently diminished. Consequently the occlusion of pFN-deficient vessels was delayed, with the majority of vessels remaining patent at the end of the 40-min observation period. We conclude that, in addition to von Willebrand factor and fibrinogen, FN plays a significant role in thrombus initiation, growth, and stability at arterial shear rates and that deficiency in each of the three platelet ligands has its own specific impact on platelet plug formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Self-citationAdhesion Mechanisms in Platelet Function
Ruggeri, Z. M., & Mendolicchio, G. L. (2007) · Circulation Research · doi:10.1161/01.res.0000267878.97021.ab · Cited by 755
The growing complexity of platelet aggregation
Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737
Arterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
Defective thrombus formation in mice lacking coagulation factor XII
Renné, T., Pozgajová, M., Grüner, S., Schuh, K., Pauer, H.-U., Burfeind, P., Gailani, D., & Nieswandt, B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050664 · Cited by 683
Plasma and cellular fibronectin: distinct and independent functions during tissue repair
To, W. S., & Midwood, K. S. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-21 · Cited by 618
Integrins: dynamic scaffolds for adhesion and signaling in platelets
Shattil, S. J., & Newman, P. J. (2004) · Blood · doi:10.1182/blood-2004-04-1257 · Cited by 601
Platelets in inflammation and thrombosis
Wagner, D. D., & Burger, P. C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000095974.95122.ec · Cited by 570
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
Furie, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26987 · Cited by 485
Vascular wall extracellular matrix proteins and vascular diseases
Xu, J., & Shi, G.-P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.008 · Cited by 381
Signaling events underlying thrombus formation
Jackson, S. P., Nesbitt, W. S., & Kulkarni, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00267.x · Cited by 380
Xu, X. R., Zhang, D., Oswald, B. E., Carrim, N., Wang, X., Hou, Y., Zhang, Q., Lavalle, C., McKeown, T., Marshall, A. H., et al. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1200008 · Cited by 338
Self-citationXu, X. R., Yousef, G. M., & Ni, H. (2018) · Blood · doi:10.1182/blood-2017-05-743187 · Cited by 325
Self-citationNew insights into form and function of fibronectin splice variants
White, E., Baralle, F., & Muro, A. (2008) · The Journal of Pathology · doi:10.1002/path.2388 · Cited by 323
The role of integrin binding sites in fibronectin matrix assembly in vivo
Leiss, M., Beckmann, K., Girós, A., Costell, M., & Fässler, R. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.06.001 · Cited by 296
Self-citationThomas, G. M., Panicot-Dubois, L., Lacroix, R., Dignat-George, F., Lombardo, D., & Dubois, C. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082297 · Cited by 271
RUGGERI, Z. M. (2009) · Microcirculation · doi:10.1080/10739680802651477 · Cited by 253
Role of plasma fibronectin in the foreign body response to biomaterials
Keselowsky, B. G., Bridges, A. W., Burns, K. L., Tate, C. C., Babensee, J. E., LaPlaca, M. C., & García, A. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.035 · Cited by 130
Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling
Yun, S., Budatha, M., Dahlman, J. E., Coon, B. G., Cameron, R. T., Langer, R., Anderson, D. G., Baillie, G., & Schwartz, M. A. (2016) · Nature Cell Biology · doi:10.1038/ncb3405 · Cited by 96
Li, R., Liu, J., Ma, J., Sun, X., Wang, Y., Yan, J., Yu, Q., Diao, J., Yang, C., Reid, L. M., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121266 · Cited by 30
Preis, M., Schneiderman, J., Koren, B., Ben-Yosef, Y., Levin-Ashkenazi, D., Shapiro, S., Cohen, T., Blich, M., Israeli-Amit, M., Sarnatzki, Y., et al. (2016) · Gene Therapy · doi:10.1038/gt.2015.104 · Cited by 13
Metadata
- Authors
- Ni, H., Yuen, P. S. T., Papalia, J. M., Trevithick, J. E., Sakai, T., Fässler, R., Hynes, R. O., & Wagner, D. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-02-26
- Volume
- 100
- Issue
- 5
- Pages
- 2415-2419
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2046499889
- Cited by
- 224
- References
- 0
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.